Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Renal epithelioid angiomyolipomas overexpress TFE3 and the TFE3-regulated gene TRIM63 in the absence of TFE3 rearrangement. | Virchows Arch | 2024 | 38971946 | PubTator, text mining | PubMed |
| Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with TFE3 gene fusion. | Open Med (Wars) | 2024 | 38953008 | PubTator, text mining | PubMed |
| TFE3-expressing perivascular epithelioid-cell tumor of the kidney and retroperitoneum: Report of a rare case. | Asian J Surg | 2024 | 38944605 | PubTator, text mining | PubMed |
| PEComa With MITF Overexpression: Clinicopathologic and Molecular Analysis of a Series of 36 Cases. | Am J Surg Pathol | 2024 | 38934541 | PubTator, text mining | PubMed |
| Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma. | Mol Cancer | 2024 | 38926757 | PubTator, text mining | PubMed |
| Blockage of Akt activation suppresses cadmium-induced renal tubular cellular damages through aggrephagy in HK-2 cells. | Sci Rep | 2024 | 38914593 | PubTator, text mining | PubMed |
| The pluripotency state of human embryonic stem cells derived from single blastomeres of eight-cell embryos. | Cells Dev | 2024 | 38914137 | PubTator, text mining | PubMed |
| Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experience. | Eur J Surg Oncol | 2024 | 38897095 | PubTator, text mining | PubMed |
| RIT2 regulates autophagy lysosomal pathway induction and protects against α-synuclein pathology in a cellular model of Parkinson's disease. | Neurobiol Dis | 2024 | 38885848 | PubTator, text mining | PubMed |
| Golgi dispersal in cancer stem cells promotes chemoresistance of colorectal cancer via the Golgi stress response. | Cell Death Dis | 2024 | 38879509 | PubTator, text mining | PubMed |
| ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum. | Mod Pathol | 2024 | 38852815 | PubTator, text mining | PubMed |
| An orbital perivascular epithelioid cell tumor (PEComa) in a 9-year-old boy: Case report and review of the literature. | J Fr Ophtalmol | 2024 | 38843609 | PubTator, text mining | PubMed |
| TFE3-rearranged renal cell carcinoma: A case report. | Asian J Surg | 2024 | 38834477 | PubTator, text mining | PubMed |
| Diffuse Intense 18 F-PSMA-1007 Uptake of the Breasts in a Woman With TFE3-Rearranged Renal Cell Carcinoma. | Clin Nucl Med | 2024 | 38775942 | PubTator, text mining | PubMed |
| The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates. | Cureus | 2024 | 38765391 | PubTator, text mining | PubMed |
| Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology. | Cytopathology | 2024 | 38751143 | PubTator, text mining | PubMed |
| Proposed diagnostic and prognostic markers of primary malignant hepatic vascular neoplasms. | Diagn Pathol | 2024 | 38741104 | PubTator, text mining | PubMed |
| Exploring G-quadruplex structure in PRCC-TFE3 fusion oncogene: Plausible use as anti cancer therapy for translocation Renal cell carcinoma (tRCC). | J Biotechnol | 2024 | 38740306 | PubTator, text mining | PubMed |
| A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature review. | Diagn Pathol | 2024 | 38730456 | PubTator, text mining | PubMed |
| [2022 WHO classification of renal cell carcinomas: Focus on papillary renal cell carcinoma]. | Ann Pathol | 2024 | 38729793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=19